Comparison of two skin protection regimes for the Prevention of Incontinence-associated Dermatitis in geriatric care (PID): a study protocol for an exploratory randomised controlled pragmatic trial
- PMID: 36175092
- PMCID: PMC9528637
- DOI: 10.1136/bmjopen-2022-065909
Comparison of two skin protection regimes for the Prevention of Incontinence-associated Dermatitis in geriatric care (PID): a study protocol for an exploratory randomised controlled pragmatic trial
Abstract
Introduction: The majority of aged long-term care receivers and patients in geriatric acute care are affected by some form of incontinence. These individuals are at risk of developing incontinence-associated dermatitis (IAD), a common type of irritant contact dermatitis caused by repeated and prolonged direct contact of the skin with urine and stool. The prevalence of IAD in these settings is high. Preventive measures include mild skin cleansing and the application of skin protecting leave-on products. Available evidence is weak regarding the comparative performance of different skin protection strategies and products due to a lack of confirmatory trials using relevant comparators and endpoints. Therefore, the overall aim of this exploratory trial is to compare the effects of three skin protection strategies to estimate effect sizes of the recently published core outcomes in IAD research.
Methods and analysis: A pragmatic three-arm, assessor-blinded, randomised controlled, exploratory trial with parallel group design will be performed, comparing film-forming and lipophilic skin protecting leave-on products for IAD prevention with standard incontinence care alone. The trial will be conducted in geriatric nursing homes and geriatric acute care settings in the federal state of Berlin, Germany. A total of n=210 participants being incontinent of urine and stool will be included. Outcomes include IAD incidence, erythema, erosion, maceration, IAD-related pain, patient satisfaction, safety, feasibility and compliance. IAD incidence of the control and intervention groups will be compared to estimate effect sizes, and the procedural feasibility of the intervention will be tested to plan a possible subsequent confirmatory randomised controlled trial.
Ethics and dissemination: The study received the approval of the ethics committee of Charité-Universitätsmedizin Berlin (EA4/043/22). Results will be disseminated through peer-reviewed open-access journals and international conferences.
Trial registration number: ClinicalTrials.gov (NCT05403762) and German Clinical Trials Register (Deutsches Register Klinischer Studien, or DRKS) (DRKS00028954).
Keywords: dermatology; geriatric dermatology; urinary incontinences.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
PREVENTion and treatment of incontinence-associated dermatitis through a codesigned manual (PREVENT-IAD): a study protocol for a feasibility cluster randomised controlled trial with a nested process evaluation.BMJ Open. 2024 Dec 23;14(12):e092338. doi: 10.1136/bmjopen-2024-092338. BMJ Open. 2024. PMID: 39719286 Free PMC article.
-
The effectiveness of a hydrocolloid crusting method versus standard care in the treatment of incontinence-associated dermatitis among adult patients in an acute care setting: A randomised controlled trial.J Tissue Viability. 2023 May;32(2):171-178. doi: 10.1016/j.jtv.2023.01.007. Epub 2023 Jan 23. J Tissue Viability. 2023. PMID: 36717288 Clinical Trial.
-
Enhancing SKIN health and safety in aged CARE (SKINCARE Trial): a study protocol for an exploratory cluster-randomized pragmatic trial.Trials. 2019 May 29;20(1):302. doi: 10.1186/s13063-019-3375-7. Trials. 2019. PMID: 31142364 Free PMC article.
-
[Incontinence-associated dermatitis: a position paper].Hautarzt. 2020 Jan;71(1):46-52. doi: 10.1007/s00105-019-04480-7. Hautarzt. 2020. PMID: 31538217 Review. German.
-
Optimal management of incontinence-associated dermatitis in the elderly.Am J Clin Dermatol. 2010;11(3):201-10. doi: 10.2165/11311010-000000000-00000. Am J Clin Dermatol. 2010. PMID: 20131923 Review.
Cited by
-
Efficacy of modified isolation in incontinence associated dermatitis.Am J Transl Res. 2023 Feb 15;15(2):1326-1333. eCollection 2023. Am J Transl Res. 2023. PMID: 36915781 Free PMC article.
-
Incontinence-Associated Dermatitis in Older Adults: A Critical Review of Risk Factors, Prevention and Management.Drugs Aging. 2025 Aug;42(8):745-754. doi: 10.1007/s40266-025-01227-z. Epub 2025 Jul 4. Drugs Aging. 2025. PMID: 40615652 Free PMC article. Review.
References
-
- Van Damme N, Vanryckeghem E, Verhaeghe S. Incontinence-associated dermatitis in elderly: a qualitative phenomenological study on patient experiences. Annual Conference of the European Pressure Ulcer Advisory Panel, Gent, Belgium, 2015.
-
- Kottner J, Beeckman D. Incontinence-associated dermatitis and pressure ulcers in geriatric patients. G Ital Dermatol Venereol 2015;150:717–29. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical